Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Equity Average: 2021-2025

Historic Equity Average for iSpecimen (ISPC) over the last 4 years, with Sep 2025 value amounting to $1.8 million.

  • iSpecimen's Equity Average fell 65.80% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 65.80%. This contributed to the annual value of $6.5 million for FY2024, which is 56.57% down from last year.
  • According to the latest figures from Q3 2025, iSpecimen's Equity Average is $1.8 million, which was up 61.31% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Equity Average ranged from a high of $28.7 million in Q1 2022 and a low of $1.1 million during Q2 2025.
  • Moreover, its 3-year median value for Equity Average was $6.5 million (2024), whereas its average is $8.2 million.
  • As far as peak fluctuations go, iSpecimen's Equity Average soared by 109.58% in 2022, and later tumbled by 82.25% in 2025.
  • Over the past 5 years, iSpecimen's Equity Average (Quarterly) stood at $20.9 million in 2021, then climbed by 2.03% to $21.4 million in 2022, then plummeted by 47.47% to $11.2 million in 2023, then plummeted by 64.25% to $4.0 million in 2024, then slumped by 65.80% to $1.8 million in 2025.
  • Its Equity Average stands at $1.8 million for Q3 2025, versus $1.1 million for Q2 2025 and $2.5 million for Q1 2025.